Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study) - Nantes Université
Article Dans Une Revue Journal of Urology Année : 2023

Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study)

Résumé

Our aim was to prospectively evaluate the diagnostic accuracy of sentinel lymph node biopsy-guided lymph node dissection compared to extended pelvic lymph node dissection in patients with intermediate- or high-risk prostate cancer.

Domaines

Médecine humaine et pathologie

Dépôt NantesU M  : Connectez-vous pour contacter le contributeur

https://nantes-universite.hal.science/hal-04756339

Soumis le : lundi 28 octobre 2024-13:20:14

Dernière modification le : mercredi 30 octobre 2024-03:22:22

Fichier non déposé

Dates et versions

hal-04756339 , version 1 (28-10-2024)

Identifiants

Citer

François Lannes, Michael Baboudjian, Alain Ruffion, Mathieu Rouy, Francesco Giammarile, et al.. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study). Journal of Urology, 2023, 209 (2), pp.364-373. ⟨10.1097/JU.0000000000003043⟩. ⟨hal-04756339⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-ST-ETIENNE HCL CNRS UNIV-AMU UNIV-LYON1 UNIV-ANGERS UDL CRCI2NA NANTES-UNIVERSITE UFR-MEDECINE-NANTES
8 Consultations
0 Téléchargements

Altmetric

Partager

More